Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine zipper protein 1 (LUZP1) is a cytoskeletal regulatory protein containing leucine zipper motifs and cross-linking domains that stabilize filamentous actin (F-actin) and regulate actin filament dynamics[4][3][2]. It localizes to the centrosome, actin cytoskeleton, and midbody, acting as a negative regulator of ciliogenesis and playing key roles in cell migration, division, and embryonic development[4][2][5][6]. Deletion or mutation of LUZP1 leads to cytoskeletal and ciliary abnormalities, with implications for congenital diseases (e.g., chromosome 1p36 deletion syndrome, Townes-Brocks syndrome) and potential contributions to cancer mechanisms by affecting cell invasion and migration[4][3][2]. LUZP1 interacts with other cytoskeletal proteins such as filamin A, ARP2, and ARP3, and contributes to the stabilization of chromatin remodeling complexes, but is not a validated target for pharmacological intervention[4][6][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine zipper protein 1 (LUZP1).